The State Food and Drug Administration news spokesman Yan Jiangxi said yesterday that the State Food and Drug Administration has made preparations for the special approval for the production of the H1N1 flu vaccine with new strains, and helped manufacturers establish direct channels of communication with the World Health Organization. , For the first time to obtain production strains. China National Institute for the Control of Pharmaceutical and Biological Products and other related departments have formulated emergency work plans so that vaccine batch issue work can be done quickly and accurately.
Yan Jianglu introduced that at present, there are two kinds of internationally recognized flu treatment drugs. One is Roche, which is developed by Roche, and the other is Leqing, which is developed by GlaxoSmithKline. At present, China has approved the import license for "Daffy", and at the same time, two Chinese enterprises have been authorized to produce this drug. "Tamiflu" has been listed on the market in China. "Le Qingqing" is still in clinical trials. In case of an emergency, the State Food and Drug Administration may temporarily import “Leqingqing” for the prevention and treatment of influenza.
“In China, there are other chemical drugs, Chinese patent medicines, and Chinese herbal compound preparations that can be used for antiviral drugs. There are many domestic production enterprises for such products, and the product quality is relatively stable, which can basically meet the needs of disease prevention and control work.” Yan Jiangxi said, The public does not have to stockpile drugs or use drugs on their own, but should take preventive and therapeutic work under the guidance of doctors and disease prevention and control departments. (Beijing reporter Cheng Fujun)
Shuttering Magnets Lever,Precast Shuttering Magnets Lever,Shuttering Magnet Released Lever,Precast Concrete Shuttering Magnets Lever
Ningbo Shine Magnetic Technology Co., Ltd. , https://www.shutteringmagnetic.com
没有评论:
发表评论